Hims & Hers Health sank -6.5% this afternoon, compared to the S&P 500's day change of -2.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Hims & Hers Health has logged a 276.5% 52 week change, compared to 18.6% for the S&P 500
-
HIMS has an average analyst rating of hold and is 27.95% away from its mean target price of $48.36 per share
-
Its trailing earnings per share (EPS) is $0.68, which brings its trailing Price to Earnings (P/E) ratio to 91.0. The Health Care sector's average P/E ratio is 22.94
-
The company's forward earnings per share (EPS) is $0.46 and its forward P/E ratio is 134.5
-
The company has a Price to Book (P/B) ratio of 25.19 in contrast to the Health Care sector's average P/B ratio is 3.19
-
The current ratio is currently 1.8, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
HIMS has reported YOY quarterly earnings growth of 313.6% and gross profit margins of 0.8%
-
The company's free cash flow for the last fiscal year was $212.28 Million and the average free cash flow growth rate is 44.7%
-
Hims & Hers Health's revenues have an average growth rate of 66.4% with operating expenses growing at 59.2%. The company's current operating margins stand at 4.2%